The Medical University of South Carolina’s Foundation for Research Development has announced a new leader.
Michael Rusnak took over as executive director effective Oct. 1. He succeed Robert Donaot, who was CEO. He remains wiht MUSC.
The foundation was created in 1995 to commercialize MUSC research, a process sometimes called “technology transfer.”
Rusnak has more than 25 years of experience in the life science industry, the university said in a statement today.
Most recently, he was director of new ventures and technology development within the technology transfer office at the University of Rochester Medical Center in New York.
Before that, he was an entrepreneur-in-residence with BCM Technologies Inc., which is part of the Baylor College of Medicine, where he was involved in starting and incubating more than five spin-off companies from the school.
He also has held senior positions in biotechnology business development with Ceros Pharmaceuticals, CombiChem and Lexicon Genetics, among others.
Notice about comments:
The Post and Courier is pleased to offer readers the enhanced ability to comment on stories. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We ask that you refrain from profanity, hate speech, personal comments and remarks that are off point.